Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pneumococcal Conjugate Vaccine”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01654263
What this trial is testing

A Phase IIb, Open-Label, Dose Ranging Study of 13-Valent Pneumococcal Conjugate Vaccine in Adults 55 Through 74 Years of Age Previously Vaccinated With 23-Valent Pneumococcal Polysaccharide Vaccine

Who this might be right for
Pneumococcal Infection
National Institute of Allergy and Infectious Diseases (NIAID) 884
Large-scale testing (Phase 3)Study completedNCT02045836
What this trial is testing

Study to Evaluate Immunogenicity and Safety Study of GSK Biologicals' Herpes Zoster (HZ) Vaccine GSK1437173A When Co-administered With Pneumovax 23™ in Adults Aged 50 Years and Older

Who this might be right for
Herpes ZosterHerpes Zoster Vaccine
GlaxoSmithKline 865
Large-scale testing (Phase 3)Study completedNCT00708682
What this trial is testing

Study Evaluating 13-Valent Pneumococcal Conjugate Vaccine in Healthy Infants in Mexico

Who this might be right for
Vaccines, Pneumococcal
Wyeth is now a wholly owned subsidiary of Pfizer 225
Testing effectiveness (Phase 2)Study completedNCT00137605
What this trial is testing

Early Versus Delayed Pneumococcal Vaccination in HIV

Who this might be right for
Pneumococcal Infections
CIHR Canadian HIV Trials Network 79
Post-approval studies (Phase 4)Study completedNCT02062281
What this trial is testing

Study of Evaluating Safety and Immunogenicity of 23-Valent Pneumococcal Polysaccharide Vaccine With Influenza Vaccine in Children and Adults

Who this might be right for
Pneumococcal InfectionInfluenza
Jiangsu Province Centers for Disease Control and Prevention 2,225
Large-scale testing (Phase 3)Study completedNCT00678301
What this trial is testing

Primary Vaccination Course in Children Receiving the Pneumococcal Vaccine GSK 1024850A, Zilbrix™ Hib and Polio Sabin™

Who this might be right for
Infections, Streptococcal
GlaxoSmithKline 365
Testing effectiveness (Phase 2)Study completedNCT01513551
What this trial is testing

The Safety, Tolerability, and Immunogenicity Profiles of a Single Dose of V114, PNEUMOVAX® 23, or PREVNAR 13® in Adults 50 Years of Age or Older (V114-002)

Who this might be right for
Pneumococcal Infections
Merck Sharp & Dohme LLC 692
Not applicableNot Yet RecruitingNCT07659470
What this trial is testing

RANDOMIZED CONTROLLED TRIAL OF TEXT MESSAGE TO INCREASE PNEUMOCOCCAL VACCINATION IN ADULTS IN CHILE.

Who this might be right for
Pneumococcal InfectionsImmunization ProgramsVaccination Coverage+4 more
Pablo Tomás Valenzuela García 43,000
Testing effectiveness (Phase 2)Study completedNCT00871338
What this trial is testing

Study to Evaluate GSK Biologicals' GSK2197870A Vaccine Given as Primary Course in Infants

Who this might be right for
Neisseria MeningitidisHaemophilus Influenzae Type b
GlaxoSmithKline 284
Early research (Phase 1)Study completedNCT04100772
What this trial is testing

Phase I Clinical Trial of a Candidate PCV13 in Healthy People Aged 6 Weeks and Above

Who this might be right for
Pneumococcal InfectionsStreptococcal InfectionsBacterial Infections
CanSino Biologics Inc. 237
Large-scale testing (Phase 3)Active Not RecruitingNCT06975878
What this trial is testing

Study of a 21-valent Pneumococcal Conjugate Vaccine in Healthy Infants From Approximately 2 Months of Age

Who this might be right for
Pneumococcal ImmunizationHealthy Volunteers
Sanofi 1,092
Post-approval studies (Phase 4)Study completedNCT00580684
What this trial is testing

Study Comparing Prevenar® to Pneumo 23 in Reducing Carriage in Children

Who this might be right for
Vaccines, PneumococcalVaccines, Pneumococcal Conjugate Vaccine
Wyeth is now a wholly owned subsidiary of Pfizer 101
Large-scale testing (Phase 3)Study completedNCT01432158
What this trial is testing

Pneumococcal Adult Kinetics Study - Understanding the B Cell Response to Pneumococcal Vaccines

Who this might be right for
Pneumococcal Disease
University of Oxford 4
Early research (Phase 1)Study completedNCT05667740
What this trial is testing

Safety, Tolerability and Immunogenicity of an Inactivated Whole-cell Pneumococcal Vaccine Gamma-PN3.

Who this might be right for
Pneumococcal Infections
GPN Vaccines 118
Large-scale testing (Phase 3)Study completedNCT00127153
What this trial is testing

V110 a Pneumococcal Vaccine in Healthy Adults (V110-013)

Who this might be right for
HealthyPneumococcal Infections
Merck Sharp & Dohme LLC 130
Early research (Phase 1)Study completedNCT02719379
What this trial is testing

Immune Response to Pneumococcal Polysaccharide Vaccine (23-valent) Predicts Asthma Status and Outcomes in Late Adolescents With Asthma

Who this might be right for
Asthma
Rohit Divekar 60
Large-scale testing (Phase 3)Study completedNCT01177722
What this trial is testing

DTaP-IPV-Hep B-PRP-T Vaccine Given With Prevenar™ and Rotarix™ in Healthy Latin American Infants

Who this might be right for
DiphtheriaTetanusWhooping Cough+2 more
Sanofi Pasteur, a Sanofi Company 1,375
Not applicableStudy completedNCT01509105
What this trial is testing

Prevenar13 Post Market Surveillance

Who this might be right for
Healthy
Pfizer 649
Large-scale testing (Phase 3)Study completedNCT00307541
What this trial is testing

Assess the Immunogenicity of GSK Biologicals' 10-valent Pneumococcal Conjugate Vaccine

Who this might be right for
Infections, StreptococcalStreptococcus Pneumoniae Vaccines
GlaxoSmithKline 120
Early research (Phase 1)Study completedNCT06550830
What this trial is testing

Clinical Trial of PCV24 in Children Aged 2-17 Years

Who this might be right for
Pneumococcal Infectious Disease
Sinovac Life Sciences Co., Ltd. 119
Next Page